Received Jun 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 79S54 | — |
expired dose of Engerix B was administration; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 47-year-old female patient who received HBV (Engerix B) (batch number 79S54, expiry date 04-APR-2025) for prophylaxis. Previously administered products included Engerix B (received 1st dose on an unknown date) and Engerix B (received 2nd dose on an unknown date). On 30-MAY-2025, the patient received the 3rd dose of Engerix B. On 30-MAY-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: expired dose of Engerix B was administration). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 02-JUN-2025 The nurse called to report that the expired dose of Engerix B was administered to a patient which led to, expired vaccine used. The vaccine administration facility was the same as primary reporter.